Bafna Pharmaceuticals Limited — Sitagliptin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Sitagliptin · $1.3M export value · DGFT Verified
Bafna Pharmaceuticals Limited is the #10 Indian exporter of Sitagliptin with $1.3M in export value and 26 verified shipments. Bafna Pharmaceuticals Limited holds a 1.7% market share in Sitagliptin exports across 4 countries. The company exports 6 pharmaceutical products worth $2.4M across 6 therapeutic categories.
Bafna Pharmaceuticals Limited — Sitagliptin Export Profile: Buyers & Destinations
Where Does Bafna Pharmaceuticals Limited Export Sitagliptin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $618.9K | 15 | 73.6% |
| PHILIPPINES | $153.1K | 6 | 18.2% |
| TANZANIA | $36.8K | 4 | 4.4% |
| GAUTEMALA | $32.5K | 3 | 3.9% |
Bafna Pharmaceuticals Limited exports Sitagliptin to 4 countries. The largest destination is SRI LANKA accounting for 73.6% of Bafna Pharmaceuticals Limited's Sitagliptin shipments, followed by PHILIPPINES (18.2%) and TANZANIA (4.4%). These destinations reflect Bafna Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sitagliptin from Bafna Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STATE PHARMACEUTICALS CORPORATION | SRI LANKA | $400.0K | 8 |
| PHARMA ASSOCIATES | SRI LANKA | $218.9K | 7 |
| MEDETHIX INC | PHILIPPINES | $144.2K | 5 |
| TO THE ORDER | GAUTEMALA | $32.5K | 3 |
| PLANET PHARMACEUTICALS LTD. | TANZANIA | $22.8K | 2 |
| PLANET PHARMACEUTICALS LIMITED | TANZANIA | $14.0K | 2 |
| MEDETHIX INC. | PHILIPPINES | $8.9K | 1 |
Bafna Pharmaceuticals Limited supplies Sitagliptin to 7 buyers globally. The largest buyer is STATE PHARMACEUTICALS CORPORATION (SRI LANKA), followed by PHARMA ASSOCIATES (SRI LANKA) and MEDETHIX INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sitagliptin Export Value and How Much Does Bafna Pharmaceuticals Limited Contribute?
India exported $46.1M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. Bafna Pharmaceuticals Limited contributes $1.3M to this total, accounting for 1.7% of India's Sitagliptin exports. Bafna Pharmaceuticals Limited ships Sitagliptin to 4 countries through 7 buyers.
What Is the Average Shipment Value for Bafna Pharmaceuticals Limited's Sitagliptin Exports?
Bafna Pharmaceuticals Limited's average Sitagliptin shipment value is $50.0K per consignment, based on 26 shipments totaling $1.3M. The largest destination is SRI LANKA (73.6% of Bafna Pharmaceuticals Limited's Sitagliptin exports).
How Does Bafna Pharmaceuticals Limited Compare to Other Indian Sitagliptin Exporters?
Bafna Pharmaceuticals Limited ranks #10 among 309 Indian Sitagliptin exporters with a 1.7% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($7.7M), MYLAN LABORATORIES LIMITED ($7.0M), SANDOZ PRIVATE LIMITED ($6.5M). Bafna Pharmaceuticals Limited processed 26 shipments to 4 destination countries.
What Sitagliptin Formulations Does Bafna Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 260000 PACKS OF SITAGLIPTIN TABLETS USP | $150.0K | 3 |
| 98230 PACKS OF SITAGLIPTIN TABLETS USP 100MG | $150.0K | 3 |
| 100000 PACKS OF SITAGLIPTIN TABLETS USP | $100.0K | 2 |
| SITAG 50 SITAGLIPTIN TABLETS USP 50MG | $54.7K | 2 |
| SITAG-100 (SITAGLIPTIN TABLETS USP 100 M | $50.0K | 1 |
| SITAG-100 SITAGLIPTIN TABLETS USP 100 MG | $50.0K | 1 |
| S-GLIPTIN (SITAGLIPTIN TABLET USP 100MG) | $32.5K | 3 |
| SITAG 100MG TABLETS SITAGLIPTINAS PHOSP | $31.1K | 1 |
| SITAG-100 SITAGLIPTIN AS PHOSPHATE MONO | $31.1K | 1 |
| SITAG-M SITAGLIPTIN AS PHOSPHATE MONOHY | $28.7K | 1 |
Bafna Pharmaceuticals Limited exports 20 distinct Sitagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 260000 PACKS OF SITAGLIPTIN TABLETS USP with 3 shipments worth $150.0K.
How Does Bafna Pharmaceuticals Limited Compare to Nearest Sitagliptin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | BETA DRUGS LIMITED | $2.4M | 85 | 1 | $28.6K |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.0M | 82 | 7 | $24.7K |
| 10 | BAFNA PHARMACEUTICALS LIMITED ★ | $1.3M | 26 | 4 | $50.0K |
| 13 | DR REDDY S LABORATORIES LTD | $1.3M | 26 | 4 | $50.0K |
| 14 | ZENTIVA PRIVATE LIMITED | $1.1M | 23 | 4 | $50.0K |
Bafna Pharmaceuticals Limited ranks #10 among 309 Indian Sitagliptin exporters. Average shipment value of $50.0K compared to the market average of $149.3K. The closest competitors by value are BETA DRUGS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Sitagliptin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 772 | 14.4% |
| DELHI AIR CARGO ACC (INDEL4) | 739 | 13.8% |
| SAHAR AIR | 735 | 13.7% |
| DELHI AIR | 513 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 217 | 4.0% |
| HYDERABAD AIR | 213 | 4.0% |
| Bombay Air | 196 | 3.7% |
| HYDERABAD ACC (INHYD4) | 191 | 3.6% |
About Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited exports 6 products worth $2.4M. Beyond Sitagliptin, top products include Terbinafine, Chlorpheniramine, Mebendazole, Terbutaline, Tamoxifen. View the complete Bafna Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Bafna Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 28 individual customs records matching Bafna Pharmaceuticals Limited exporting Sitagliptin, covering 20 formulations to 4 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Export Data from Bafna Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bafna Pharmaceuticals Limited's Sitagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bafna Pharmaceuticals Limited
Full Company Profile →
6 products · $2.4M total trade · 6 categories
Sitagliptin Stats
Company Overview
Top Products by Bafna Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Bafna Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current shipment-level data, contact TransData Nexus.